Literature DB >> 28966459

Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Stacey L Murthy1, Michael A Hitchcock1, Tiana R Endicott-Yazdani1, John T Watson1, John R Krause1.   

Abstract

While the World Health Organization included Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) as a provisional entity of a lymphoma occurring in older individuals without any known immunodeficiency in 2008, it has since been recognized that this entity may occur in younger individuals. As a result, the 2016 revision has substituted the modifier "elderly" with "not otherwise specified" (NOS). The NOS highlights that there are more specific entities with neoplastic EBV-positive large B cells such as lymphomatoid granulomatosis. Diagnosis requires that there be no other cause of immunodeficiency and that other more specific entities with neoplastic EBV plus large B cells be excluded. We present the case of an 81-year-old woman hospitalized for generalized weakness, increasing confusion, unexplained weight loss, and intermittent fevers. Examination showed lymphadenopathy, lesions in the liver and small intestine, and a very high EBV viral load. She experienced a rapid demise and at autopsy was found to have EBV+ DLBCL, NOS.

Entities:  

Year:  2017        PMID: 28966459      PMCID: PMC5595389          DOI: 10.1080/08998280.2017.11930222

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  5 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 2.  Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

Authors:  Jorge J Castillo; Brady E Beltran; Roberto N Miranda; Semra Paydas; Eric S Winer; James N Butera
Journal:  Oncologist       Date:  2011-01-06

Review 3.  EBV-positive diffuse large B-cell lymphoma of the elderly.

Authors:  Chi Young Ok; Thomas G Papathomas; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

4.  Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.

Authors:  Ting-Xun Lu; Jin-Hua Liang; Yi Miao; Lei Fan; Li Wang; Xiao-Yan Qu; Lei Cao; Qi-Xing Gong; Zhen Wang; Zhi-Hong Zhang; Wei Xu; Jian-Yong Li
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

5.  Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.

Authors:  Chen-Ge Song; Jia-Jia Huang; Ya-Jun Li; Yi Xia; Yu Wang; Xi-Wen Bi; Wen-Qi Jiang; Hui-Qiang Huang; Tong-Yu Lin; Zhi-Ming Li
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  5 in total
  3 in total

Review 1.  Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Zbigniew Wyżewski; Matylda Barbara Mielcarska; Karolina Paulina Gregorczyk-Zboroch; Anna Myszka
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis.

Authors:  Wei Yan; Shawn Xiang Li; Hongyu Gao; Wei Yang
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

3.  Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin.

Authors:  Jonathan Wawire; Shahin Sayed; Zahir Moloo; Aliyah R Sohani
Journal:  J Glob Oncol       Date:  2019-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.